LDN193189

LDN193189 inhibits ectopic ossification and it is a potential agent in the treatment of NSCLC lung tumors, showing significant in-vivo clinical utility. LDN193189 has been used to reduce ectopic ossification in a mouse model of Fibrodysplasia ossificans progressiva.

Read more
€0.00 (tax incl.)
Reference:
SM23-1
Brand:
Cell Guidance Systems
Product Details
SM23-1

Data sheet

Size
1 mg
URL - Product
http://cellgs.e2ecdn.co.uk/Downloads/SM23_datasheet.pdf

Menu

Settings

Please sign in first.

Sign in